No time to die: the consensus immunoscore for predicting survival and response to chemotherapy of locally advanced colon cancer patients in a multicenter international study

Paolo A. Asciertoa Melanoma, Cancer Immunotherapy and Innovative Therapies Unit, Istituto Nazionale Tumori IRCCS Fondazione “G. Pascale”, Napoli, Italy

https://orcid.org/0000-0002-8322-475X View further author information

Francesco M. Marincolab Refuge Biotechnologies, Menlo Park, CA, USAView further author information

Bernard A. Foxc Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR, USA;d Laboratory of Molecular and Tumor Immunology, Earle A. Chiles Research Institute, Robert W. Franz Cancer Center, Providence Portland Medical Center, Portland, OR, USAView further author information

Jérôme Galone Laboratory of Integrative Cancer Immunology, INSERM, Paris, France;f Equipe Labellisée Ligue Contre le Cancer, Paris, France;g Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, Paris, FranceCorrespondence[email protected]

https://orcid.org/0000-0001-9635-1339 View further author information

No time to die: the consensus immunoscore for predicting survival and response to chemotherapy of locally advanced colon cancer patients in a multicenter international study

Articles from other publishers (9)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

No time to die: the consensus immunoscore for predicting survival and response to chemotherapy of locally advanced colon cancer patients in a multicenter international study

Citations (9)

Articles from other publishers (9)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date